On January 22, 2024, Bridge Biotherapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,315 KRW | +10.24% | +9.72% | -29.53% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.53% | 40.97M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 1.99999872 billion in funding